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Countermeasures

Problem/Impact Statement:

Scope:
In Scope: The workflows that Pharmacy/Supply Chain utilize to obtain and communicate the most up to date
information for drug and IV shortages at the twice-a-week Drug/IV Shortage Meeting.
Out of Scope: Out of scope will be all of the other workflows that Supply Chain and Pharmacy utilize to communicate
with one another in between the meetings.

Status

Observe Pharmacy /Supply Chain drug and IV shortage meeting to
determine current gaps in drug/IV shortage management process

Stephen Tyzik

11/16/17

Completed

Develop a drug shortage prioritization matrix that the Pharmacy can use
to assess criticality and feed into a priority based communication pathway

Stephen Tyzik

January 2018

Completed

Facilitate a meeting between Supply Chain and Pharmacy to outline gaps
in current process, triage the root causes and develop agreed upon action
plans/timelines/needed support to implement improvement strategies

Jason Tremblay and
Stephen Tyzik

January 2018

Completed

Jason Tremblay, Rita
Renaud, Jody Batsford,
Katherine Anderson and
Stephen Tyzik

February 2018

Completed

Outcomes

Baseline Metrics/Current State:

Study

Previously, the inpatient Pharmacy team at Maine Medical Center did not have a robust process for efficiently managing
the day to day information for all drugs considered to be on a “shortage”. Due to the number of people that needed to be
at the meetings to assess severity and properly develop mitigation strategies, each meeting came at a cost of approximately
$429.95. When multiplied by the number of meetings that occurred prior to the interventions, the resulting overall cost
was between $20,637.60 and $23,733.24.

FDA Strategies to
Effectively Manage
Drug Shortages

MMC Improvement Strategies (Implemented)

Develop and/or
Streamline Internal
Processes

1. On a daily basis Supply Chain reviews items that drop below the re-order point and < 7 days supply on hand (SOH) which triggers
communication to the Pharmacy and development of an internal and external mitigation strategy. Those > 7 days SOH are triaged for
discussion at the twice a week Pharmacy/Supply Chain Drug Shortage Meeting.
2. On a daily basis Pharmacy utilizes a prioritization matrix (discussed below), any drugs that change to a red priority score with < 7
days SOH trigger a mitigation strategy. Those > 7 day SOH get triaged to the Drug Shortage Meeting.

Improve Data and
Response Tracking

On a daily basis, the Pharmacy updates their drug shortage spreadsheet which automatically updates a prioritization matrix so that key
variables (SOH, re-supply ETA, daily usage) trigger the development of an appropriate mitigation strategy

Clarify
Roles/Responsibility

In conjunction with the streamlined processes above, a swimlane diagram was developed to articulate the roles of Supply Chain,
Materials Management, Pharmacy and Risk and Patient Safety within the daily management of Drug/IV shortages.

Enhance Public
Communications about
Drug Shortages

In alignment with the development of the above mitigation strategies, each of the color codes on the prioritization matrix (Red,
Orange, Yellow, Green) correspond to an associated communication plan.

Develop Methods to
Incentivize and
Prioritize Quality

The Pharmacy/Supply Chain Drug Shortage Meeting experienced a > 250% reduction in minutes (35  < 10) which was dedicated to
discussion/planning to manage IV fluid shortages and a 100% reduction in minutes (40  20) which was dedicated to
discussion/planning to manage drug shortages.

Develop risk-based
approaches to identify
early warning to prevent
supply disruptions.

For Supply Chain and Pharmacy, both of them have transformed their IV Fluid/Drug shortage management spreadsheets with
prioritization driven visual management. In real time, the updating of multiple variables give them real time feedback to the urgency of
a situation surrounding an IV fluid and/or drug.

Implementation of these strategies led to a meeting time of 24 minutes, which meets
the target and reduces the salary cost of the meeting from $429.95 to $171.98

Act

Plan

To reduce the time of the twice-a-week Drug/IV Shortage Meeting from 75 minutes to 30 minutes
To reduce the time of the IV shortage discussion/planning from 35 minutes to < 10
To reduce the time of the drug shortage discussion/planning from 40 minutes to < 20
To eliminate 100% of unnecessary communication between the Pharmacy and Supply Chain outside of the Drug/IV
Shortage Meeting

Root Cause Analysis:

Completion
Date

Work with Supply Chain to develop an IV Fluid shortage prioritization
matrix that Supply Chain and Materials Management can use to assess
criticality and feed into a priority based communication pathway

Goal/Objective:
1.
2.
3.
4.

Owner

Action

Do

In September of 2017, Hurricane Maria struck the island of Puerto Rico where over 50 pharmaceutical factories had
previously operated. The impact of this was felt not only in the drastic reduction of products that are produced on the
island such as Baxter’s mini-bags, but it also exacerbated supply chain issues for key drugs nationwide. As Pharmacy
team’s across the country raced to collect information and develop mitigation strategies for navigating these shortages, the
need to streamline internal planning and communication is critical. At Maine Medical Center, the Pharmacy Department
and Supply Chain did not have a consistent and reliable process for communication, planning and real-time updates. This
yielded a tremendous amount of waste before, during and after the drug/IV shortage meeting.

Next Steps
Continue to utilize prioritization matrix as Drug/IV Fluid shortages evolve and utilize similar process improvement
strategies for challenges moving forward.

